Iwona Stroynowski
Overview
Explore the profile of Iwona Stroynowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renthal N, Guidry P, Shanmuganad S, Renthal W, Stroynowski I
Immunogenetics
. 2010 Oct;
63(1):57-64.
PMID: 20967542
Although the human nonclassical class Ib major histocompatibility complex (Mhc) locus, HLA-G, is known to act as an immune suppressor in immune-privileged sites, little is currently known regarding participation of...
2.
Swanson 2nd P, Pack C, Hadley A, Wang C, Stroynowski I, Jensen P, et al.
J Exp Med
. 2008 Jun;
205(7):1647-57.
PMID: 18541714
Although immunity against intracellular pathogens is primarily provided by CD8 T lymphocytes that recognize pathogen-derived peptides presented by major histocompatibility complex (MHC) class Ia molecules, MHC class Ib-restricted CD8 T...
3.
Chiang E, Stroynowski I
J Immunol
. 2006 Aug;
177(4):2123-30.
PMID: 16887971
The mouse multimember family of Qa-2 oligomorphic class I MHC genes is continuously undergoing duplications and deletions that alter the number of the two "prototype" Qa-2 sequences, Q8 and Q9....
4.
Guidry P, Stroynowski I
J Immunol
. 2005 Oct;
175(8):5248-59.
PMID: 16210630
The gastrointestinal tract is populated by a multitude of specialized immune cells endowed with receptors for classical (class Ia) and nonclassical (class Ib) MHC proteins. To identify class I products...
5.
Chen M, Tabaczewski P, Truscott S, Van Kaer L, Stroynowski I
J Immunol
. 2005 Jul;
175(2):1047-55.
PMID: 16002705
Hepatic expression levels of class I MHC Ags are generally regarded as very low. Because the status of these Ags and their ability to present peptides are important for the...
6.
Chiang E, Stroynowski I
J Immunol
. 2005 Apr;
174(9):5367-74.
PMID: 15843534
Current peptide-based immunotherapies for treatment of model cancers target tumor Ags bound by the classical MHC class I (class Ia) molecules. The extensive polymorphism of class Ia loci greatly limits...
7.
Chiang E, Stroynowski I
J Immunol
. 2004 Sep;
173(7):4394-401.
PMID: 15383569
Although CTL and polymorphic, classical MHC class I molecules have well defined roles in the immune response against tumors, little is currently known regarding the participation of nonpolymorphic, nonclassical MHC...
8.
Gao J, Liu X, Wen J, Caligiuri M, Stroynowski I, Zheng P, et al.
Blood
. 2003 Aug;
102(13):4456-63.
PMID: 12933569
Optimal activation of T cells requires delivery of both antigenic and costimulatory signals. It is unclear, however, if the function of the natural killer (NK) cells is also modulated by...
9.
Chiang E, Henson M, Stroynowski I
J Immunol
. 2003 Apr;
170(9):4515-23.
PMID: 12707328
One of the principal mechanisms of tumor immune evasion is alteration of class I MHC expression. We have identified defects contributing to down-regulation of class I MHC expression in the...
10.
Chiang E, Henson M, Stroynowski I
J Immunol
. 2002 Feb;
168(5):2200-11.
PMID: 11859106
The cytotoxic activity of NK cells is regulated by class I MHC proteins. Although much has been learned about NK recognition of class I autologous targets, the mechanisms of NK...